Richard Scolyer: Received the 10th and last dose of a personalised anticancer vaccine
Richard Scolyer, Senior Staff Specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital, shared a post on X:
“Earlier this week, I received my 10th (and last) dose of a personalised anticancer vaccine.
It started more than a year ago. Whilst on each occasion I had quite a sore arm for few days afterwards, thankfully I otherwise felt fine/had no systemic complications.
I hope the vaccine can stimulate my immune system to fight my wretched brain cancer. But who knows if it is effective.
As has happened with each vaccination, I also had approximately 150 ml of blood taken for research purposes.
Many thanks to everyone involved and their kindness and care.”
Professor Richard Scolyer AO is a Senior Staff Specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital, Sydney, and Co-Medical Director at Melanoma Institute Australia. He is also a Conjoint Professor at Sydney Medical School, University of Sydney. In June 2021, he was appointed Officer of the Order of Australia for his distinguished service in melanoma and skin cancer research. Additionally, he is Vice Chair of the Melanoma Expert Panel for the AJCC Cancer Staging System and co-leads the Australian Melanoma Genome Project.
More post featuring Richard Scolyer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023